In 2010, Stryker received subpoenas from the U.S. Department of Justice regarding the OtisKnee. The subpoena filed with the Securities and Exchange Commission regarded regulatory matters related to the sales and marketing of the devices.
The OtisKnee device was manufactured by OtisMed, which Stryker acquired in 2009. The federal government has yet to accept the offer.
Related Articles on Stryker:
InVivo Therapeutics Names Former Stryker Exec Robert Housler Vice President of Business Development
Former Stryker CEO Stephen MacMillan Seeking Johnson & Johnson Position
Stryker, Others Found Environmentally Preferable Purchasing Business Leadership Coalition
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
